Baird Medical Investment Holdings Limited (BDMD)
| Market Cap | 32.35M -51.4% |
| Revenue (ttm) | 24.49M -23.1% |
| Net Income | -15.91M |
| EPS | n/a |
| Shares Out | 42.21M |
| PE Ratio | n/a |
| Forward PE | 6.97 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 50,012 |
| Open | 0.7609 |
| Previous Close | 0.7800 |
| Day's Range | 0.7300 - 0.8200 |
| 52-Week Range | 0.6605 - 3.7000 |
| Beta | -1.16 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 3, 2026 |
About BDMD
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distribu... [Read more]
Financial Performance
Financial StatementsNews
Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited (“Baird Medical” or the “Company”) (Nasdaq: BDMD), a global medical technology company focused on the development...
Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology
Company Engaged with Interventional Radiology Community at Leading Global Congress in Copenhagen Company Engaged with Interventional Radiology Community at Leading Global Congress in Copenhagen
Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026
Revenue increase driven by significant growth in the United States and other strategic markets Revenue increase driven by significant growth in the United States and other strategic markets
Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan
NEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), announced that the BD-GT Microwave Ablation System and T-1610 Disp...
Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally
NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”) and Tianjin Yuanshan Medical Technology Co., Ltd., operating under ...
Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina
First procedures in two new markets highlight growing global adoption of Baird Medical's minimally invasive microwave ablation technology NEW YORK, June 29, 2026 /PRNewswire/ -- Baird Medical Investme...
Baird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial Expansion
Enhanced U.S. Presence Centralizes Operations as Company Executes Global Growth Strategy NEW YORK, June 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" o...
Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update
Full year 2025 revenue of $22.5 million, impacted by policy-driven slowdown in Mainland China Advancing global expansion with appointment of seasoned commercial leader, Mark Saxton, as CEO of Baird Me...
Baird Medical Advances Clinical Education with Expert-Led Workshops in Indonesia
NEW YORK, March 16, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) techno...
Baird Medical Expands Global Reach with Regulatory Clearance in Argentina
NEW YORK, March 12, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) techno...
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026
NEW YORK, March 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Accelerates Global Registration of AI-Driven Surgical Software
NEW YORK, March 4, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announ...
Baird Medical Accelerates U.S. Expansion at NASOIE 2026
NEW YORK, March 2, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology
NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences
NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital
NEW YORK, Feb. 11, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan
NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technolo...
Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass
NEW YORK, Jan. 28, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) techno...
Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key Capital
NEW YORK, Jan. 26, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare Conference
NEW YORK, Jan. 20, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam
NEW YORK, Jan. 7, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announced...
Baird Medical Establishes U.S. Manufacturing Base to Accelerate Global Expansion and Future R&D
NEW YORK , Dec. 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announc...
Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion
NEW YORK , Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation
NEW YORK , Nov. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its official l...
Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice
NEW YORK , Oct. 27, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the clinical ...